10-Q Filing

REVOLUTION MEDICINES, INC. CIK: 1628171 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0000950170-22-008496`
Period End Date	20220331
Filing Date	20220509
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	rvmd-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 79 Income Statement 26 Cash Flow Statement 69 Stockholders Equity 20 Comprehensive Income 6

Balance Sheet 79 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par or stated value per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par or stated value per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$108.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$351.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$97.67M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$468.56M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$421.09M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$5.38M	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$5.93M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.21M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.79M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$589.77M	USD	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	74.14M	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	74.23M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$534.34M	USD	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	74.14M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.54M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.06M	USD	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	74.23M	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$58.57M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$59.69M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$59.61M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$59.88M	USD	Point-in-time
Goodwill	`Goodwill`	$14.61M	USD	Point-in-time
Goodwill	`Goodwill`	$14.61M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.74M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.74M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$851.00K	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$758.00K	USD	Point-in-time
Total assets	`Assets`	$737.99M	USD	Point-in-time
Total assets	`Assets`	$682.77M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.17M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.06M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$27.72M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$25.52M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$6.33M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$6.21M	USD	Point-in-time
Deferred revenue, current	`ContractWithCustomerLiabilityCurrent`	$11.43M	USD	Point-in-time
Deferred revenue, current	`ContractWithCustomerLiabilityCurrent`	$12.36M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$60.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$57.46M	USD	Point-in-time
Deferred revenue, noncurrent	`ContractWithCustomerLiabilityNoncurrent`	$5.66M	USD	Point-in-time
Deferred revenue, noncurrent	`ContractWithCustomerLiabilityNoncurrent`	$6.57M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$7.44M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$7.44M	USD	Point-in-time
Operating lease liability, noncurrent	`OperatingLeaseLiabilityNoncurrent`	$59.58M	USD	Point-in-time
Operating lease liability, noncurrent	`OperatingLeaseLiabilityNoncurrent`	$60.42M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$634.00K	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$1.63M	USD	Point-in-time
Total liabilities	`Liabilities`	$131.78M	USD	Point-in-time
Total liabilities	`Liabilities`	$135.42M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively; zero shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively; zero shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 300,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively; 74,227,672 and 74,142,619 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Common stock, $0.0001 par value; 300,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively; 74,227,672 and 74,142,619 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.06B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.06B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.28M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-376.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-452.64M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-510.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$722.58M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$474.68M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$550.99M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$602.57M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$682.77M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$737.99M	USD	Point-in-time

Income Statement 26 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.58M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$10.13M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$56.49M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$40.86M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$9.04M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.67M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$65.53M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$47.53M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-57.95M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-37.40M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$302.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$233.00K	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$12.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$302.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$221.00K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-57.65M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-37.18M	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-57.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.18M	USD	1 Quarter
Net loss per share attributable to common stockholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.53	USD	1 Quarter
Net loss per share attributable to common stockholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.78	USD	1 Quarter
Weighted-average common shares used to compute net loss per share, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	74.16M	shares	1 Quarter
Weighted-average common shares used to compute net loss per share, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	70.42M	shares	1 Quarter

Cash Flow Statement 69 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-37.18M	USD	1 Quarter
Net loss	`ProfitLoss`	$-57.65M	USD	1 Quarter
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	1 Quarter
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-19.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$267.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$267.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$6.64M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$3.39M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$671.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$901.00K	USD	1 Quarter
Net amortization of premium on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-534.00K	USD	1 Quarter
Net amortization of premium on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-648.00K	USD	1 Quarter
Amortization of operating lease right-of-use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$740.00K	USD	1 Quarter
Amortization of operating lease right-of-use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.12M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.17M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-546.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.42M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.26M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.13M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-492.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-2.11M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.20M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-1.84M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-2.49M	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-670.00K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-719.00K	USD	1 Quarter
Other noncurrent assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$114.00K	USD	1 Quarter
Other noncurrent assets	`IncreaseDecreaseInOtherNoncurrentAssets`	-	USD	1 Quarter
Other noncurrent liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$1.03M	USD	1 Quarter
Other noncurrent liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$853.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-37.25M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-55.16M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$111.82M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$114.04M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromMaturityOfMarketableSecurities`	$119.93M	USD	1 Quarter
Maturities of marketable securities	`ProceedsFromMaturityOfMarketableSecurities`	$157.73M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.58M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.89M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$44.02M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.31M	USD	1 Quarter
Proceeds from issuance of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$281.71M	USD	1 Quarter
Proceeds from issuance of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from issuance of common stock under equity incentive plans	`ProceedsFromStockPlans`	$555.00K	USD	1 Quarter
Proceeds from issuance of common stock under equity incentive plans	`ProceedsFromStockPlans`	$305.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$282.26M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$305.00K	USD	1 Quarter
Net increase/(decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-10.83M	USD	1 Quarter
Net increase/(decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$247.33M	USD	1 Quarter
Cash, cash equivalents and restricted cash - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$352.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$99.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.23M	USD	Point-in-time
Cash, cash equivalents and restricted cash - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$105.35M	USD	Point-in-time
Cash, cash equivalents and restricted cash - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$352.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$99.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.23M	USD	Point-in-time
Cash, cash equivalents and restricted cash - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$105.35M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$108.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$351.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$97.67M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.74M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$99.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$352.68M	USD	Point-in-time
Vesting of early exercised options and restricted stock	`VestingOfEarlyExercisedOptionsAndRestrictedStock`	$46.00K	USD	1 Quarter
Vesting of early exercised options and restricted stock	`VestingOfEarlyExercisedOptionsAndRestrictedStock`	$31.00K	USD	1 Quarter
Purchases of property and equipment in accounts payable and accrued expenses and other current liabilities	`CapitalExpendituresIncurredButNotYetPaid`	$882.00K	USD	1 Quarter
Purchases of property and equipment in accounts payable and accrued expenses and other current liabilities	`CapitalExpendituresIncurredButNotYetPaid`	$1.67M	USD	1 Quarter
Unpaid deferred offering costs	`UnpaidDeferredOfferingCosts`	$564.00K	USD	1 Quarter
Unpaid deferred offering costs	`UnpaidDeferredOfferingCosts`	$89.00K	USD	1 Quarter

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$722.58M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$474.68M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$550.99M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$602.57M	USD	Point-in-time
Issuance of common stock upon offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$281.14M	USD	1 Quarter
Issuance of common stock pursuant to stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$555.00K	USD	1 Quarter
Issuance of common stock pursuant to stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$305.00K	USD	1 Quarter
Issuance of common stock pursuant to stock option exercises, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	58,122.00	shares	1 Quarter
Vesting of early exercised stock options	`AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExerciseOfStockOptions`	$46.00K	USD	1 Quarter
Vesting of early exercised stock options	`AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExerciseOfStockOptions`	$31.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.64M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.39M	USD	1 Quarter
Net unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-53.00K	USD	1 Quarter
Net unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-908.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-57.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.18M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$722.58M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$474.68M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$550.99M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$602.57M	USD	Point-in-time

Comprehensive Income 6 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-57.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.18M	USD	1 Quarter
Unrealized gain (loss) on investments, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-53.00K	USD	1 Quarter
Unrealized gain (loss) on investments, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-908.00K	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-37.23M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-58.55M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.